Strategic partnerships NLC Health Ventures collaborates with notable players like Verily and supports joint ventures such as Serda Therapeutics and Exolvo Biosciences. This indicates a favorable channel for co-investment, co-development, and combined go-to-market approaches with large life sciences ecosystems.

Healthtech focus Operating as a healthtech venture builder with a track record of funding and launching biotech and therapeutics ventures, NLC presents opportunities to position AI, data analytics, and cloud-based solutions to accelerate research, development, and patient delivery.

Funding momentum Recent financing rounds and multi-million euro funding signals capacity for strategic partnerships and pilot programs. Engage with NLC on early-stage pilot funding, outcomes-based projects, or follow-on rounds for high-potential healthtech ventures.

Scale and operations With a mid-sized team and a broad tech stack (AWS, Google Cloud, OpenAI, Slack, HubSpot, Webflow), NLC is prepared to implement scalable digital platforms. This presents opportunities to offer integrated cloud-based infrastructure, AI enablement, and customer engagement tools tailored to portfolio companies.

Market reach and exits Active investments in Europe with partnerships to accelerate growth imply open pathways for exit strategy planning, regulatory and market access support, and strategic acquisitions. Propose market intelligence services, due diligence tooling, and partner ecosystems to de-risk investments.